Condition: Cholangiocarcinoma · Gallbladder Cancer and Extrahepatic Cholangiocarcinoma · Pancreatic Cancer · Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
The diagnosis of malignant biliary strictures remains a challenging aspect of biliary endoscopy. Molecular biological testing techniques based on bile have been reported to improve detection rates. However, whether the combination of bile-based omics studies and biliary brush cytology/biopsy can enhance diagnostic sensitivity has not yet been reported. This study aims to collect bile from patients with malignant biliary strictures, screen for molecular markers associated with biliary malignancies through multi-omics analysis, and subsequently validate these markers to establish a bile-based molecular diagnostic model.
This description comes directly from the study's public registry record.
Xiaobo Cai, MD · 86+13918177123 · caixiaobo1979@hotmail.com
Always discuss trial participation with your own doctor first.
| Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Shanghai, China, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07007832